The Development of the International Intestinal Failure Registry and an Overview of its Results

Yaron Avitzur1, Eric Pahl2, Robert Venick3,4

  • 1Division of Gastroenterology, Hepatology, and Nutrition, Transplant and Regenerative Center, Group for Improvement of Intestinal Function and Treatment, The Hospital for Sick Children, Toronto, Ontario, Canada.

Insights

The International Intestinal Failure Registry (IIFR) tracks pediatric intestinal failure (IF) cases globally. It aims to improve understanding and treatment of this rare condition through worldwide data collection and analysis.

Area of Science:

  • Pediatric Gastroenterology and Surgery
  • Rare Diseases
  • Clinical Registries

Background:

  • Pediatric intestinal failure (IF) research is limited by small, single-center studies, hindering data interpretation and knowledge advancement.
  • Past large-scale multicenter collaborations have concluded, leaving a need for continued international data collection.
  • The International Intestinal Rehabilitation and Transplant Association initiated the IIFR to address these gaps.

Approach:

  • The International Intestinal Failure Registry (IIFR) was established to prospectively collect data on children with IF.
  • A pilot phase (2018) assessed registry feasibility with 204 patients, refining protocols.
  • The current phase, launched in 2021, includes 362 children from 26 global centers.

Key Points:

  • The IIFR aims to characterize the natural history of pediatric IF and establish a global platform for evidence-based interventions.
  • The registry facilitates benchmarking and promotes standardized care for children with intestinal failure.
  • Findings from the pilot and current phases are reviewed, highlighting the registry's development and challenges.

Conclusions:

  • The IIFR represents a crucial ongoing effort to overcome data limitations in pediatric IF research.
  • It provides a vital worldwide platform for advancing the understanding and management of pediatric intestinal failure.
  • Continued international collaboration through registries like IIFR is essential for improving outcomes in rare pediatric diseases.